Status:
COMPLETED
DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer
Lead Sponsor:
Barbara Ann Karmanos Cancer Institute
Conditions:
Chronic Lymphocytic Leukemia
Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This phase II trial studies how well the DIScussion of COst (DISCO) application (app) works in improving financial outcomes in patients with hematologic cancer. The DISCO app is an electronic, highly ...
Detailed Description
PRIMARY OBJECTIVE: I. To assess the effectiveness of the DISCO app on prompting patient-oncologist treatment cost discussions during patient-physician interactions (as observed in video recordings), ...
Eligibility Criteria
Inclusion
- ONCOLOGISTS: Eligible if they treat patients with chronic lymphocytic leukemia (CLL), chronic myelogenous leukemia (CML), or multiple myeloma (MM) cancers
- PATIENTS: Able to read and write in English
- PATIENTS: Have a confirmed diagnosis of CLL, CML, or MM cancers
- PATIENTS: Are scheduled to see an oncologist at Karmanos Cancer Institute (KCI) Detroit or KCI Farmington Hills/Weisberg for an initial or change in treatment discussion
Exclusion
- None
Key Trial Info
Start Date :
February 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2022
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04282343
Start Date
February 25 2020
End Date
October 21 2022
Last Update
May 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States, 48201